Individuals with Hyperuricemia Tend to Use More Analgesics Compared to Those with Normal Uric Acid Levels—Is Asymptomatic Hyperuricemia Truly Without Symptoms? - Top-Institutions - MDSpire

Individuals with Hyperuricemia Tend to Use More Analgesics Compared to Those with Normal Uric Acid Levels—Is Asymptomatic Hyperuricemia Truly Without Symptoms?

  • By

  • Janis Timsans

  • Jenni Emilia Kauppi

  • Vappu Rantalaiho

  • Anne Kerola

  • Kia Hakkarainen

  • Tiina Lehto

  • Hannu Kautiainen

  • Markku Kauppi

  • December 11, 2025

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Rheumatology
    • Nephrology
    • Pain Management

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology
    • Epidemiology
    • Nephrology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Rheumatology
    • Nephrology
    • Clinical Pharmacology

  • #4

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology
    • Nephrology
    • Pharmacology

  • #5

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Rheumatology
    • Epidemiology
    • Nephrology

Original Source(s)

Individuals with Hyperuricemia Tend to Use More Analgesics Compared to Those with Normal Uric Acid Levels—Is Asymptomatic Hyperuricemia Truly Without Symptoms?

  • by Janis Timsans, Jenni Emilia Kauppi, Vappu Rantalaiho, Anne Kerola, Kia Hakkarainen, Tiina Lehto, Hannu Kautiainen, Markku Kauppi

  • December 11, 2025

Related Content

Creation and assessment of a comprehensive and interpretable AI model for forecasting gout recurrence in hospitalized individuals: a real-world, ambispective multicenter cohort investigation in China

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study